Tue, February 12, 2019
Mon, February 11, 2019
Fri, February 8, 2019
Thu, February 7, 2019
Wed, February 6, 2019
Tue, February 5, 2019
Mon, February 4, 2019
Fri, February 1, 2019
Thu, January 31, 2019
Wed, January 30, 2019

Charles Duncan Downgraded (VNDA) to Hold on, Feb 6th, 2019

Charles Duncan of Cantor Fitzgerald, Downgraded "Vanda Pharmaceuticals Inc." (VNDA) to Hold on, Feb 6th, 2019.

Charles has made no other calls on VNDA in the last 4 months.



There are 3 other peers that have a rating on VNDA. Out of the 3 peers that are also analyzing VNDA, 1 agrees with Charles's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Derek Archila of "Oppenheimer" Downgraded from Buy to Hold and Held Target at $29 on, Tuesday, December 11th, 2018


These are the ratings of the 2 analyists that currently disagree with Charles


  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $47 on, Friday, December 7th, 2018
  • Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $26 on, Thursday, November 8th, 2018